Home > Insider Trading > Filing (0001126234-14-000048)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1126234	Newlink Genetics Corp	(NLNK)	Pharmaceutical Preparations (2834)	421491350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591245	W. Carl Langren	C/O Newlink Genetics Corporation 2503 South Loop Dr., Suite 5100 Ames IA 50010	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-01-08	2,400	$0.00	62,391	No	4	G	Direct
Common Stock	Acquisiton	2014-01-08	1,200	$0.00	2,500	No	4	G	Indirect	By Son
Common Stock	Disposition	2014-01-15	1,413	$29.95	7,016	No	4	S	Indirect	By Pension Plan
Common Stock	Disposition	2014-01-15	1,414	$29.95	7,015	No	4	S	Indirect	By Spouse's Pension Plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	G	Indirect	By Son
No	4	S	Indirect	By Pension Plan
No	4	S	Indirect	By Spouse's Pension Plan

Footnotes

Includes 5,700 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on January 2, 2015, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.